Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Therapeutic Strategies in Lymphoid Malignancies [[electronic resource] ] : An Immunotherapeutic Approach
| Therapeutic Strategies in Lymphoid Malignancies [[electronic resource] ] : An Immunotherapeutic Approach |
| Autore | Hillmen P |
| Pubbl/distr/stampa | Oxford, : Atlas Medical Publishing Ltd, 2005 |
| Descrizione fisica | 1 online resource (238 p.) |
| Disciplina | 616.994420637 |
| Altri autori (Persone) | WitzigTE |
| Collana | Therapeutic Strategies |
| Soggetto topico |
Cancer
Lymphatics Lymphoma Immunotherapy Lymphoproliferative Disorders Neoplasms by Histologic Type Immunomodulation Lymphatic Diseases Biological Therapy Immunoproliferative Disorders Neoplasms Immune System Diseases Diseases Therapeutics Hemic and Lymphatic Diseases Diagnostic Techniques and Procedures |
| ISBN |
1-280-30974-1
9786610309740 1-84692-556-8 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Contents; Contributors; 1. The history of immunotherapy for lymphoid malignancies; 2. Immunological markers of lymphoid malignancy; 3. Diagnostic and prognostic markers of lymphoid malignancies; the latest genetic, cytogenetic and haematological parameters; 4. CD20: B-cell antigen and therapeutic target; 5. Rituximab and chemotherapy for non-Hodgkin's lymphomas: improved response and survival; 6. Rituximab and chemotherapy in elderly patients with lymphomas; 7. Maintenance therapy with rituximab; 8. Interferon-alpha in lymphoid malignancies
9. Radioimmunotherapy safety: radiation protection, administration guidelines, isotope comparison, and quality of life issues10. Radioimmunotherapy with Yttrium-90-labelled ibritumomab tiuxetan (ZevalinTM) for B-cell Hodgkin's lymphoma; 11. Radioimmunotherapy combinations with other therapies for non-Hodgkin's lymphoma; 12. 131I-Tositumomab therapy for the treatment ofl ow-grade non-Hodgkin's lymphoma; 13. CD52 as a target for immunotherapy; 14. Relapsed and refractory CLL: a clinical challenge 15. Optimising the use of alemtuzumab in CLL: new therapeutic end points, disease stratification and therapy earlier in the disease course16. Alemtuzumab in combination with other therapies in B-cell lymphoproliferative disorders; 17. The role of alemtuzumab in allogeneic stem cell transplantation; 18. Alemtuzumab in T-cell malignancies; 19. Epratuzumab: A new humanised monoclonal antibody to CD22; 20. Education and management of patients undergoing immunotherapy and radioimmunotherapy; 21. Antibody therapy for chronic lymphocytic leukemia; Index |
| Record Nr. | UNISA-996339091503316 |
Hillmen P
|
||
| Oxford, : Atlas Medical Publishing Ltd, 2005 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Therapeutic Strategies in Prostate Cancer [[electronic resource]]
| Therapeutic Strategies in Prostate Cancer [[electronic resource]] |
| Autore | Feneley Mark |
| Pubbl/distr/stampa | Oxford, : Atlas Medical Publishing Ltd, 2007 |
| Descrizione fisica | 1 online resource (280 p.) |
| Disciplina |
616.99/463
616.9946306 |
| Altri autori (Persone) | PayneHeather |
| Collana | Therapeutic Strategies |
| Soggetto topico |
Prostate -- Cancer -- Treatment
Prostate -- Cancer Prostatectomy Radiotherapy Genital Neoplasms, Male Prostatic Diseases Urogenital Neoplasms Genital Diseases, Male Neoplasms by Site Male Urogenital Diseases Diseases Neoplasms Prostatic Neoplasms |
| ISBN |
1-281-40852-2
9786611408527 1-84692-580-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Contents; Editors and Conributors; Section I: Prevention and diagnosis; Section II: Regional prostate cancer - localized and locallyadvanced cancer; Section III: Advanced prostate cancer - distant metastases; Section IV: Management of complications; Abbreviations; Index |
| Record Nr. | UNISA-996339091003316 |
|
Feneley Mark
|
||
| Oxford, : Atlas Medical Publishing Ltd, 2007 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Therapeutic Strategies in Pulmonary Arterial Hypertension [[electronic resource]]
| Therapeutic Strategies in Pulmonary Arterial Hypertension [[electronic resource]] |
| Autore | Peacock A |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Oxford, : Atlas Medical Publishing Ltd, 2009 |
| Descrizione fisica | 1 online resource (101 p.) |
| Disciplina | 616.24 |
| Altri autori (Persone) | BarberàJ |
| Collana | Therapeutic Strategies |
| Soggetto topico |
Hypertension, Pulmonary
Pulmonary artery Pulmonary hypertension |
| ISBN |
1-282-09392-4
9786612093920 1-84692-610-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Contents; Editors and Contributors; Chapter 1: Imaging of the right heart and pulmonary circulation; Chapter 2: Exercise testing and haemodynamics; Chapter 3: Epidemiology of pulmonary arterial hypertension; Chapter 4: Current treatment of PAH: prostanoids, phosphodiesterase-5 inhibitors and stimulators of soluble guanylate cyclase; Chapter 5: The future treatment of pulmonary hypertension; Chapter 6: Endothelin receptor antagonists; Chapter 7: Gene and stem cell therapy in pulmonary arterial hypertension; Abbreviations; Index |
| Record Nr. | UNISA-996339089303316 |
|
Peacock A
|
||
| Oxford, : Atlas Medical Publishing Ltd, 2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Therapeutic Strategies in Thrombosis [[electronic resource]]
| Therapeutic Strategies in Thrombosis [[electronic resource]] |
| Autore | Kristensen S. D. <1955-> |
| Pubbl/distr/stampa | Oxford, : Atlas Medical Publishing Ltd, 2005 |
| Descrizione fisica | 1 online resource (405 p.) |
| Disciplina | 616.13506 |
| Altri autori (Persone) |
De CaterinaR. <1954->
MoliternoDavid J |
| Collana | Therapeutic Strategies |
| Soggetto topico |
Thrombolytic therapy
Thrombosis -- Treatment Thrombosis Cardiovascular Diseases Medicine Health & Biological Sciences |
| ISBN |
1-280-30995-4
9786610309955 1-84692-543-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Contents; Contributors; 1. Arterial thrombosis: a brief overview; 2. Aspirin: a risk-based strategy; 3. Clopidogrel and other platelet ADP inhibitors; 4. Glycoprotein IIb/IIIa inhibitors; 5. Unfractionated heparin and low-molecular-weight heparin in coronary heart disease; 6. Intravenous direct thrombin inhibition: acute coronary syndromes and heparin-induced thrombocytopaenia; 7. Direct thrombin inhibition during percutaneous coronary interventions; 8. Pentasaccharide and other factor Xa inhibitors
9. Direct thrombin inhibition - thromboprophylaxis, deep venous thrombosis, atrial fibrillation and coronary artery disease10. Warfarin after acute myocardial infarction; 11. Thrombolytic therapy and concomitantantithrombotic therapy; 12. Pre-hospital reperfusion therapy; 13. Antithrombotic strategies in patients undergoing primary percutaneous intervention; 14. Antithrombotic management in patients with prosthetic valves; 15. Stroke: thrombolysis and antithrombotic therapy; 16. Atrial fibrillation: antithrombotic therapy; 17, Venous thromboembolism: pathophysiology and diagnosis 18. Antithrombotic therapy in venous thrombosis and pulmonary embolism19.Prevention and treatment of venous and arterial thrombosis in patients with specific conditions: diabetes, hypercoagulable states, pregnancy and renal diseases; 20. Monitoring of antithrombotic drugs; Index |
| Record Nr. | UNISA-996339091403316 |
|
Kristensen S. D. <1955->
|
||
| Oxford, : Atlas Medical Publishing Ltd, 2005 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
